Meyka Pro banner
OPKO Health, Inc.

OPKO Health, Inc. (OPK) Stock Overview

Explore OPKO Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

OPKNASDAQ
HealthcareBiotechnology
$1.24
$0.02(1.64%)
U.S. Market opens in 8h 20m

OPKO Health, Inc. (OPK)

Meyka AI Score

Z

Key Financials

Market Cap936.3M
P/E Ratio-4.47
EPS (TTM)$-0.27
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$1.12
3 Months$1.56
1 Year Target$1.46

OPK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of OPKO Health, Inc. (NASDAQ: OPK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, OPKO Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OPK on the NASDAQ shows an RSI of 40.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.46 for the NASDAQ listing.

Key metrics behind OPKO Health, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.47 and a market capitalization of 936.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OPK on the NASDAQ.

Price Performance (NASDAQ: OPK)

1-Day Change
1.64%
5-Day Change
1.64%
1-Month Change
-18.95%
3-Month Change
3.33%
6-Month Change
-3.88%
Year-to-Date (YTD) Change
-1.59%
1-Year Change
-8.15%
3-Year Change
-30.34%
5-Year Change
-65.75%
All-Time (Max) Change
-72.44%

Contact Information

305 575 4100
4400 Biscayne Boulevard, Miami, FL, 33137

Company Facts

22,750 Employees
IPO DateNov 2, 1995
CountryUS
Actively Trading

Frequently Asked Questions